O	0	8	Survivin	Survivin	NN	B-NP
O	9	19	expression	expression	NN	I-NP
O	20	22	in	in	IN	B-PP
B-Cancer	23	29	breast	breast	NN	B-NP
I-Cancer	30	39	carcinoma	carcinoma	NN	I-NP
O	39	40	:	:	:	O
O	41	52	correlation	correlation	NN	B-NP
O	53	57	with	with	IN	B-PP
O	58	67	apoptosis	apoptosis	NN	B-NP
O	68	71	and	and	CC	I-NP
O	72	81	prognosis	prognosis	NN	I-NP
O	81	82	.	.	.	O

O	84	94	BACKGROUND	BACKGROUND	NN	B-NP
O	94	95	:	:	:	O
O	96	104	Survivin	Survivin	NN	B-NP
O	105	107	is	be	VBZ	B-VP
O	108	109	a	a	DT	B-NP
O	110	115	novel	novel	JJ	I-NP
O	116	125	inhibitor	inhibitor	NN	I-NP
O	126	128	of	of	IN	B-PP
O	129	138	apoptosis	apoptosis	NN	B-NP
O	139	147	commonly	commonly	RB	B-VP
O	148	156	detected	detect	VBN	I-VP
O	157	159	in	in	IN	B-PP
B-Tissue	160	167	tissues	tissue	NNS	B-NP
O	168	174	during	during	IN	B-PP
B-Developing_anatomical_structure	175	180	fetal	fetal	JJ	B-NP
O	181	192	development	development	NN	I-NP
O	193	196	and	and	CC	B-PP
O	197	199	in	in	IN	B-PP
B-Cancer	200	206	cancer	cancer	NN	B-NP
O	206	207	,	,	,	O
O	208	211	but	but	CC	O
O	212	215	not	not	RB	O
O	216	223	usually	usually	RB	B-ADVP
O	224	226	in	in	IN	B-PP
O	227	233	normal	normal	JJ	B-NP
B-Tissue	234	241	tissues	tissue	NNS	I-NP
O	241	242	.	.	.	O

O	243	245	It	It	PRP	B-NP
O	246	249	has	have	VBZ	B-VP
O	250	254	been	be	VBN	I-VP
O	255	264	suggested	suggest	VBN	I-VP
O	265	269	that	that	IN	B-SBAR
O	270	273	the	the	DT	B-NP
O	274	284	expression	expression	NN	I-NP
O	285	287	of	of	IN	B-PP
O	288	292	this	this	DT	B-NP
O	293	300	protein	protein	NN	I-NP
O	301	304	may	may	MD	B-VP
O	305	307	be	be	VB	I-VP
O	308	310	of	of	IN	B-PP
O	311	321	prognostic	prognostic	JJ	B-NP
O	322	334	significance	significance	NN	I-NP
O	335	337	in	in	IN	B-PP
B-Cancer	338	345	gastric	gastric	JJ	B-NP
O	345	346	,	,	,	I-NP
B-Cancer	347	357	colorectal	colorectal	JJ	I-NP
O	357	358	,	,	,	I-NP
O	359	362	and	and	CC	I-NP
B-Cancer	363	370	bladder	bladder	NN	I-NP
I-Cancer	371	381	carcinomas	carcinoma	NNS	I-NP
O	381	382	.	.	.	O

O	383	385	We	We	PRP	B-NP
O	386	394	assessed	assess	VBD	B-VP
O	395	403	survivin	survivin	NN	B-NP
O	404	414	expression	expression	NN	I-NP
O	415	417	in	in	IN	B-PP
B-Cancer	418	424	breast	breast	NN	B-NP
I-Cancer	425	435	carcinomas	carcinoma	NNS	I-NP
O	436	447	correlating	correlate	VBG	B-VP
O	448	455	results	result	NNS	B-NP
O	456	460	with	with	IN	B-PP
O	461	471	expression	expression	NN	B-NP
O	472	474	of	of	IN	B-PP
O	475	480	other	other	JJ	B-NP
O	481	494	antiapoptotic	antiapoptotic	JJ	I-NP
O	495	496	(	(	(	O
O	496	499	bcl	bcl	NN	B-NP
O	499	500	-	-	HYPH	O
O	500	501	2	2	CD	B-NP
O	501	502	,	,	,	O
O	503	506	bcl	bcl	NN	B-NP
O	506	507	-	-	HYPH	B-NP
O	507	508	x	x	NN	I-NP
O	508	509	)	)	)	O
O	510	513	and	and	CC	O
O	514	526	proapoptotic	proapoptotic	JJ	B-NP
O	527	528	(	(	(	O
O	528	531	bax	bax	NN	B-NP
O	531	532	)	)	)	O
O	533	540	markers	marker	NNS	B-NP
O	540	541	,	,	,	O
O	542	546	with	with	IN	B-PP
O	547	557	prognostic	prognostic	JJ	B-NP
O	558	568	parameters	parameter	NNS	I-NP
O	568	569	,	,	,	O
O	570	573	and	and	CC	O
O	574	578	with	with	IN	B-PP
O	579	588	prognosis	prognosis	NN	B-NP
O	588	589	.	.	.	O

O	590	596	DESIGN	DESIGN	NN	B-NP
O	596	597	:	:	:	O
O	598	606	Paraffin	Paraffin	NN	B-NP
O	606	607	-	-	HYPH	B-NP
O	607	615	embedded	embed	VBN	I-NP
B-Cancer	616	624	sections	section	NNS	I-NP
O	625	627	of	of	IN	B-PP
O	628	630	37	37	CD	B-NP
B-Cancer	631	637	breast	breast	NN	I-NP
I-Cancer	638	648	carcinomas	carcinoma	NNS	I-NP
O	649	653	were	be	VBD	B-VP
O	654	667	immunostained	immunostaine	VBN	I-VP
O	668	671	for	for	IN	B-PP
O	672	680	survivin	survivin	NN	B-NP
O	680	681	,	,	,	O
O	682	685	bcl	bcl	NN	B-NP
O	685	686	-	-	HYPH	O
O	686	687	2	2	CD	B-NP
O	687	688	,	,	,	O
O	689	692	bcl	bcl	NN	B-NP
O	692	693	-	-	HYPH	O
O	693	694	x	x	SYM	B-NP
O	694	695	,	,	,	O
O	696	699	and	and	CC	O
O	700	703	bax	bax	NN	B-NP
O	703	704	.	.	.	O

O	705	715	Expression	Expression	NN	B-NP
O	716	719	was	be	VBD	B-VP
O	720	729	evaluated	evaluate	VBN	I-VP
O	730	732	in	in	IN	B-PP
O	733	739	normal	normal	JJ	B-NP
B-Tissue	740	746	breast	breast	NN	I-NP
I-Tissue	747	753	tissue	tissue	NN	I-NP
O	754	757	and	and	CC	I-NP
B-Cancer	758	767	carcinoma	carcinoma	NN	I-NP
O	767	768	,	,	,	O
B-Cellular_component	769	775	nuclei	nucleus	NNS	B-NP
O	776	779	and	and	CC	O
B-Organism_substance	780	789	cytoplasm	cytoplasm	NN	B-NP
O	789	790	,	,	,	O
O	791	793	as	as	IN	B-SBAR
O	794	803	intensity	intensity	NN	B-NP
O	804	805	(	(	(	O
O	805	806	0	0	CD	B-NP
O	807	809	to	to	TO	O
O	810	811	3	3	CD	B-NP
O	811	812	+	+	SYM	B-NP
O	812	813	)	)	)	O
O	813	814	,	,	,	O
O	815	818	and	and	CC	O
O	819	829	percentage	percentage	NN	B-NP
O	830	832	of	of	IN	B-PP
O	833	841	positive	positive	JJ	B-NP
B-Cell	842	847	cells	cell	NNS	I-NP
O	847	848	.	.	.	O

O	849	856	RESULTS	RESULTS	NNS	B-NP
O	856	857	:	:	:	O
O	858	866	Survivin	Survivin	NN	B-NP
O	867	877	expression	expression	NN	I-NP
O	878	881	was	be	VBD	B-VP
O	882	887	noted	note	VBN	I-VP
O	888	890	in	in	IN	B-PP
O	891	893	30	30	CD	B-NP
O	894	895	(	(	(	O
O	895	897	81	81	CD	B-NP
O	897	898	%	%	NN	I-NP
O	898	899	)	)	)	O
O	900	902	of	of	IN	B-PP
B-Cancer	903	909	breast	breast	NN	B-NP
I-Cancer	910	920	carcinomas	carcinoma	NNS	I-NP
O	920	921	,	,	,	O
O	922	925	and	and	CC	O
O	926	928	in	in	IN	B-PP
O	929	935	normal	normal	JJ	B-NP
B-Tissue	936	942	breast	breast	NN	I-NP
I-Tissue	943	949	tissue	tissue	NN	I-NP
O	949	950	,	,	,	O
O	951	953	in	in	IN	B-PP
B-Cellular_component	954	960	nuclei	nucleus	NNS	B-NP
O	960	961	,	,	,	O
O	962	965	and	and	CC	O
B-Organism_substance	966	975	cytoplasm	cytoplasm	NN	B-NP
O	975	976	.	.	.	O

O	977	982	There	There	EX	B-NP
O	983	986	was	be	VBD	B-VP
O	987	988	a	a	DT	B-NP
O	989	1000	significant	significant	JJ	I-NP
O	1001	1012	correlation	correlation	NN	I-NP
O	1013	1014	(	(	(	O
O	1014	1015	P	P	NN	B-NP
O	1015	1016	=	=	SYM	B-VP
O	1016	1017	0	0	CD	B-NP
O	1017	1018	.	.	.	O
O	1018	1021	022	022	CD	B-NP
O	1021	1022	)	)	)	O
O	1023	1030	between	between	IN	B-PP
O	1031	1039	survivin	survivin	NN	B-NP
O	1040	1043	and	and	CC	I-NP
O	1044	1047	bcl	bcl	NN	I-NP
O	1047	1048	-	-	HYPH	B-NP
O	1048	1049	x	x	NN	I-NP
O	1050	1060	expression	expression	NN	I-NP
O	1060	1061	;	;	:	O
O	1062	1070	survivin	survivin	NN	B-NP
O	1071	1074	and	and	CC	I-NP
O	1075	1078	bcl	bcl	NN	I-NP
O	1078	1079	-	-	HYPH	O
O	1079	1080	x	x	SYM	B-NP
O	1081	1087	tended	tend	VBD	B-VP
O	1088	1090	to	to	TO	I-VP
O	1091	1100	correlate	correlate	VB	I-VP
O	1101	1105	with	with	IN	B-PP
O	1106	1113	overall	overall	JJ	B-NP
O	1114	1122	survival	survival	NN	I-NP
O	1123	1124	(	(	(	O
O	1124	1125	P	P	NN	B-NP
O	1125	1126	=	=	SYM	B-VP
O	1126	1127	0	0	CD	B-NP
O	1127	1128	.	.	SYM	I-NP
O	1128	1131	072	072	CD	I-NP
O	1132	1135	and	and	CC	I-NP
O	1136	1137	0	0	CD	I-NP
O	1137	1138	.	.	.	I-NP
O	1138	1141	075	075	CD	I-NP
O	1141	1142	,	,	,	O
O	1143	1155	respectively	respectively	RB	B-ADVP
O	1155	1156	)	)	)	O
O	1156	1157	,	,	,	O
O	1158	1161	but	but	CC	B-PP
O	1162	1165	not	not	RB	I-PP
O	1166	1170	with	with	IN	B-PP
O	1171	1178	disease	disease	NN	B-NP
O	1178	1179	-	-	HYPH	O
O	1179	1183	free	free	JJ	B-NP
O	1184	1192	survival	survival	NN	I-NP
O	1193	1194	(	(	(	O
O	1194	1195	P	P	NN	B-NP
O	1195	1196	=	=	SYM	B-VP
O	1196	1197	0	0	CD	B-NP
O	1197	1198	.	.	SYM	I-NP
O	1198	1200	19	19	CD	I-NP
O	1201	1204	and	and	CC	I-NP
O	1205	1206	0	0	CD	I-NP
O	1206	1207	.	.	.	O
O	1207	1209	18	18	CD	B-NP
O	1209	1210	,	,	,	O
O	1211	1223	respectively	respectively	RB	B-ADVP
O	1223	1224	)	)	)	O
O	1224	1225	.	.	.	O

O	1226	1231	There	There	EX	B-NP
O	1232	1235	was	be	VBD	B-VP
O	1236	1238	no	no	DT	B-NP
O	1239	1250	correlation	correlation	NN	I-NP
O	1251	1253	of	of	IN	B-PP
O	1254	1262	survivin	survivin	NN	B-NP
O	1263	1267	with	with	IN	B-PP
O	1268	1271	bcl	bcl	NN	B-NP
O	1271	1272	-	-	HYPH	B-NP
O	1272	1273	2	2	CD	I-NP
O	1274	1276	or	or	CC	O
O	1277	1280	bax	bax	NN	B-NP
O	1281	1291	expression	expression	NN	I-NP
O	1291	1292	,	,	,	O
O	1293	1295	or	or	CC	O
O	1296	1300	with	with	IN	B-PP
O	1301	1306	other	other	JJ	B-NP
O	1307	1317	prognostic	prognostic	JJ	I-NP
O	1318	1328	parameters	parameter	NNS	I-NP
O	1329	1330	(	(	(	O
O	1330	1333	age	age	NN	B-NP
O	1333	1334	,	,	,	O
B-Cancer	1335	1340	tumor	tumor	NN	B-NP
O	1341	1345	size	size	NN	I-NP
O	1345	1346	,	,	,	O
O	1347	1357	histologic	histologic	JJ	B-NP
O	1358	1362	type	type	NN	I-NP
O	1362	1363	,	,	,	O
O	1364	1374	histologic	histologic	JJ	B-NP
O	1375	1380	grade	grade	NN	I-NP
O	1380	1381	,	,	,	O
B-Multi-tissue_structure	1382	1387	nodal	nodal	JJ	B-NP
O	1388	1394	status	status	NN	I-NP
O	1394	1395	,	,	,	O
O	1396	1399	and	and	CC	O
B-Cancer	1400	1405	tumor	tumor	NN	B-NP
O	1406	1411	stage	stage	NN	I-NP
O	1411	1412	)	)	)	O
O	1413	1414	(	(	(	O
O	1414	1415	P	P	NN	B-NP
O	1415	1416	>	>	SYM	B-ADJP
O	1416	1417	0	0	CD	B-NP
O	1417	1418	.	.	.	I-NP
O	1418	1420	05	05	CD	I-NP
O	1420	1421	)	)	)	O
O	1421	1422	.	.	.	O

O	1423	1433	CONCLUSION	CONCLUSION	NN	B-NP
O	1433	1434	:	:	:	O
O	1435	1438	The	The	DT	B-NP
O	1439	1447	majority	majority	NN	I-NP
O	1448	1449	(	(	(	O
O	1449	1451	81	81	CD	B-NP
O	1451	1452	%	%	NN	I-NP
O	1452	1453	)	)	)	O
O	1454	1456	of	of	IN	B-PP
B-Cancer	1457	1463	breast	breast	NN	B-NP
I-Cancer	1464	1474	carcinomas	carcinoma	NNS	I-NP
O	1475	1479	show	show	VBP	B-VP
O	1480	1488	survivin	survivin	NN	B-NP
O	1489	1499	expression	expression	NN	I-NP
O	1500	1505	which	which	WDT	B-NP
O	1506	1516	correlates	correlate	VBZ	B-VP
O	1517	1521	with	with	IN	B-PP
O	1522	1525	bcl	bcl	NN	B-NP
O	1525	1526	-	-	HYPH	O
O	1526	1527	x	x	SYM	B-NP
O	1527	1528	,	,	,	O
O	1529	1536	another	another	DT	B-NP
O	1537	1550	antiapoptotic	antiapoptotic	JJ	I-NP
O	1551	1557	marker	marker	NN	I-NP
O	1557	1558	,	,	,	O
O	1559	1562	and	and	CC	O
O	1563	1567	both	both	DT	B-NP
O	1568	1575	markers	marker	NNS	I-NP
O	1576	1580	tend	tend	VBP	B-VP
O	1581	1583	to	to	TO	I-VP
O	1584	1593	correlate	correlate	VB	I-VP
O	1594	1598	with	with	IN	B-PP
O	1599	1608	prognosis	prognosis	NN	B-NP
O	1608	1609	.	.	.	O

